The forthcoming targeted agent, such as menin inhibitory, can also cause DS, characterized by symptoms like fever, arthralgias, leukocytosis, pleural or pericardial effusions, and respiratory or renal failure in severe cases [25,55,56,57,58,59,60,61]. Here, MEN1 is linked to acute kidney injury.